^
BIOMARKER:

FGFR fusion

i
Other names: FGFR, Fibroblast Growth Factor Receptor
Related biomarkers:
FGFR fusion
Childhood B Acute Lymphoblastic Leukemia
dasatinib
Sensitive: A2 - Guideline
FGFR fusion
Urothelial Cancer
erdafitinib
Sensitive: C2 – Inclusion Criteria
FGFR fusion
Pancreatic Cancer
pemigatinib
Sensitive: C2 – Inclusion Criteria
FGFR fusion
Urothelial Cancer
erdafitinib + JNJ-63723283
Sensitive: C3 – Early Trials
FGFR fusion
Cholangiocarcinoma
pemigatinib
Sensitive: C3 – Early Trials
FGFR fusion
Urothelial Cancer
pemigatinib
Sensitive: C3 – Early Trials
FGFR fusion
NSCLC
pemigatinib
Sensitive: C3 – Early Trials
FGFR fusion
Astrocytoma
pemigatinib
Sensitive: C3 – Early Trials
FGFR fusion
Uterine Cancer
pemigatinib
Sensitive: C3 – Early Trials
FGFR fusion
Gallbladder Cancer
pemigatinib
Sensitive: C3 – Early Trials
FGFR fusion
Head and Neck Cancer
pemigatinib
Sensitive: C3 – Early Trials
FGFR fusion
GBM
erdafitinib
Sensitive: C3 – Early Trials
FGFR fusion
Pancreatic Cancer
erdafitinib
Sensitive: C3 – Early Trials
FGFR fusion
Salivary Gland Cancer
erdafitinib
Sensitive: C3 – Early Trials